Previous imaging studies have suggested that there is an age-related decline in brain serotonin (5-hydroxytryptamine) measures in healthy subjects. This paper addresses whether the availability of 5-hydroxytryptamine receptor 1B (5-HT 1B ) is seen to decrease with aging via PET imaging. Methods: Methods: Fortyeight healthy control subjects (mean age ± SD, 30 ± 10 y; age range, 18-61 y; 33 men, 15 women) underwent C-P943 scanning on a high-resolution PET tomograph. Regions were examined with and without gray matter masking, the latter in an attempt to control for age-related gray matter atrophy on Recently, evidence that aging has an effect on the 5-hydroxytryptamine system has also brought about a focus on 5-HT 1B (1,9). 5-HT 1B is part of the 5-HT 1 family and is a G-protein-coupled metabotropic receptor spanning 7 transmembranes (10). 5-HT 1B is expressed as an autoreceptor on serotoninergic neurons, where it is the predominant presynaptic modulator of 5-hydroxytryptamine release in the brain, and as a heteroreceptor on nonserotoninergic neurons (10). Although the only clinically available 5-HT 1B
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MATERIALS AND METHODS

Subjects
Forty-eight healthy, medication-free volunteers were recruited through public advertisement to participate in the study. Subjects were between 18 and 61 y old (mean ± SD, 30 ± 10 y). Thirty-three (69%) were male. Thirty-seven (77%)
were Caucasian, 5 (10%) were African-American, and 2 each were Hispanic, Healthcare). The GE Microlab was used in some of the preparations as a source of the requisite C-methyl iodide.
Scanning and Imaging Procedures
PET was performed with the selective 5-HT 1B antagonist radiotracer C-P943.
All scanning was performed on a high-resolution research tomograph = 0.01, P = 0.9144). As in previous P943 studies, PET data were used to produce a time-activity curve for the cerebellum, which was used as a reference. The multilinear reference tissue model has been previously validated in a P943 study and was used to produce parametric images of BP ND (17) .
A second summed image (0-10 min after injection) was created from the motion-corrected PET data and registered to the subject's MR image, which in turn was registered (12-parameter affine transformation) to an MRI template (Montreal Neurologic Institute space).
Regions of interest were based on the Anatomic Automatic Labeling template delineated on an MRI template (18). The primary region was the cerebral cortex, which was a summed result of the frontal, occipital, parietal, and temporal cortices. A secondary analysis examined subcortical areas (amygdala, caudate, hippocampus, hypothalamus, pallidum, putamen, and thalamus). These results were obtained using individual parametric images that were resliced in template space using the PET-to-MRI and the MRI-totemplate transforms.
To account for possible partial-volume effects, a binary gray matter mask (GMM) was used. For these results, individual MR images were segmented with FAST (FMRIB's Automated Segmentation Tool, version 3.1) to obtain masking of gray matter, white matter, and cerebrospinal fluid. The individual GMMs were then applied to the regions from the Anatomic Automatic Labeling template to obtain the mean regional values limited to gray matter voxels.
Statistical Analysis
All outcomes were summarized descriptively and assessed for normality before analysis using normal probability plots and Kolmogorov test statistics. linear mixed model was used to model the independent and joint effects of age (continuous) and cortical region (within-subject factor) on BP ND values.
The interaction between region and age was modeled, and slopes for each cortical region were estimated post hoc. Within-subject correlations were accounted for by fitting 3 variance-covariance structures to the data (unstructured, compound symmetry, and heterogeneous compound symmetry) and then selecting the best-fitting structure according to the Bayesian information criterion. Subcortical regions were analyzed as secondary subregions and adjusted using the Bonferroni adjustment. All analyses were conducted using SAS, version 9.1 (SAS Institute Inc.). Table 1 presents average 5-HT 1B (±SD) BP ND levels for cortical and segmented cortical gray matter regions, along with the slope and correlations with age in the 47 reported subjects. Significant negative associations between age and 5-HT 1B BP ND were observed in all cortical regions, and total cortical BP ND averaged an 8% decline per decade studied (9% in total cortical gray matter using GMM). The results of the primary mixed model showed an overall significant effect of age on both total BP ND (F 1,45 = 21.6, P < 0.0001) and total BP ND after GMM (F 1,45 = 28.6, P < 0.0001), averaged across all cortical regions. These effects are depicted in Figures 1 and 2 , respectively. Consistent with the univariate results, primary mixed-model slope estimates for the individual 5-HT 1B BP ND cortical regions (with and without GMM) remained significant (P = <0.01) with age ( Figs. 3 and 4, respectively) . Subcortical region (without GMM) correlations were largely insignificant when age and 5-HT 1B BP ND were examined, with the exception of the hypothalamus (r = #0.28, P = 0.05), pallidum (r = +0.39, P = 0.01), and putamen (r = +0.41, P < 0.01). GMM subcortical results found a difference in the putamen (r = +0.32, P = 0.03) and a trend-level difference in the pallidum (r = +0.26, P = 0.08), with all other regions nonsignificant. Subcortical results remained significant after a multiple-comparison correction in the pallidum (Bonferroniadjusted P = 0.05) and putamen (Bonferroni-adjusted P = 0.03) without GMM.
RESULTS
Sex and race had no significant effects on these results.
DISCUSSION
This work has furthered our understanding of the role of aging on the serotonin system by demonstrating age effects on 5-HT 1B with the PET radiotracer C-P943. A decrease in BP ND was found throughout cortical areas with increased age. These findings are consistent with the existing literature on aging and serotonin, which has shown decreases in the density of 5-HT 1A and 5-HT 2A in aging (3) (4) (5) (6) 8, 19) . Different methods to control for cerebral atrophy were used in these cited studies. The current work used a gray matter segmentation to create a gray matter binary mask, and although this method is not necessarily sensitive to all partial-volume effects, the retention of findings argues against the possibility that cerebral atrophy is responsible for the decreases in 5-HT 1B with aging. Furthermore, a recent study that examined 5-HT 2A and aging found that a partial-volume correction was not necessary when similar parameters (cortical regions of interest, high-resolution scanning, and a healthy population) were examined (19) .
Our sample comprised mostly male subjects (69%) who were younger than 61 y, and the sample was also limited in distribution across age regions (with most subjects under 40 y). This is a limitation to the current analysis, as it is susceptible to bias induced by fewer older subjects and sex (although no current sex effects were found). Further studies including a more balanced distribution of older subjects could be justified to verify that 5-HT 1B decline is a linear phenomenon in advanced age. Although the multilinear reference tissue model is a validated method to examine these data, another potential limitation in this study was the lack of available arterial blood flow data in most subjects to rule out potential confounders such as age-related effects of the cerebellar time-activity curve.
The preliminary finding of increased 5-HT 1B BP ND in the pallidum and putamen (which retained significance after multiple corrections) could be of interest, as there are no current reports of increasing serotonin receptor brain levels with age in any region. If confirmed in further work, these subcortical areas could be a focus of a potentially novel process. 11 http://jnm.snmjournals.org/content/53/9/1411.full Finally, whereas the focus of this paper was to investigate age effects on 5-HT 1B , the functional impact of this finding could extend into cognitive effects such as memory or learning that have been implicated in 5-HT 1B decline in a host of preclinical work (1, 9, 14) . In the only other work to date on an aged human population, postmortem examination found reduced 5-HT 1B density in Alzheimer patients, compared with controls, in the frontal and temporal cortices (20). Interestingly, cognitive decline was associated with more 5-HT 1B in that study. The authors attributed this finding to a compensation of 5-HT 1B heteroreceptors for a deteriorated cholinergic system (i.e., the heteroreceptors, which function to inhibit acetylcholine, led to worse cognitive performance due to decreased acetylcholine in an already acetylcholinedeficient state in Alzheimer disease). It remains to be seen if 5-HT 1B medications could have a clinical effect on age-specific cognitive problems, but the current results support further investigation of this potential learning and memory treatment.
CONCLUSION
The findings of this study indicate that age is a relevant factor for 5-HT 1B in the cortex of healthy adults.
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